Effects of Immersive Virtual Reality on Balance, Mobility, and Fatigue in Patients With Multiple Sclerosis
1 other identifier
interventional
39
1 country
1
Brief Summary
Gait disorder, imbalance, and fatigue are the most frequently reported complaints in Multiple Sclerosis (MS), a chronic neurodegenerative disease. The first symptoms in patients with MS are emerging in the age range 20-50 and these patients need long-term rehabilitation. The virtual reality applications developed for these problems which affect the quality of life negatively and cause disability in the following periods may be a good alternative for conventional rehabilitation applications. In this long-term where motivation is important, virtual reality applications in different environments provide patients with the opportunity to do many different tasks amused. In recent years, the vividness has been increased by the 3D virtual reality headsets. The aim of this study is to investigate the effects of immersive virtual reality on the balance, mobility, and fatigue in patients with MS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable multiple-sclerosis
Started Apr 2018
Shorter than P25 for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 9, 2018
CompletedFirst Submitted
Initial submission to the registry
April 10, 2018
CompletedFirst Posted
Study publicly available on registry
April 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedOctober 12, 2018
October 1, 2018
5 months
April 10, 2018
October 11, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Berg Balance Scale
Berg Balance Scale (BBS) rates performance from 0 (cannot perform) to 4 (normal performance) on 14 items. It has shown to be a valid measure with high inter and interrater reliability for people with MS.
Change between baseline and after 8 weeks of intervention will be assessed
Secondary Outcomes (6)
Timed Up and Go Test
Change between baseline and after 8 weeks of intervention will be assessed
Modified Sensory Organization Test
Change between baseline and after 8 weeks of intervention will be assessed
One-leg standing duration
Change between baseline and after 8 weeks of intervention will be assessed
Activities-specific Balance Confidence
Change between baseline and after 8 weeks of intervention will be assessed
Fatigue Severity Scale
Change between baseline and after 8 weeks of intervention will be assessed
- +1 more secondary outcomes
Study Arms (3)
Virtual reality group
EXPERIMENTALIn virtual reality group, 30 minutes of Pilates training, 10 minutes of rest and then 20 minutes of virtual reality will be applied.
Dynamic Balance Training
ACTIVE COMPARATORIn the "Dynamic Balance Training" group, 20 minutes of dynamic balance exercises will be applied after Pilates training.
Control group
NO INTERVENTIONThe control group will be taught relaxation exercises and will be asked to perform the exercises at home.
Interventions
Immersive virtual reality training protocol consisted of "Football" and "Guillotine" games.
Dynamic balance training protocol consisted of holding the ball and running away from the ball with a physiotherapist.
Eligibility Criteria
You may qualify if:
- Participants who are ambulatory and volunteer to participate to the study, in a stable phase of the disease, without relapses in the last 1 month, with an EDSS between 0-5,5.
You may not qualify if:
- Participants who have orthopedic, vision, hearing, or perception problems
- Patients who have any cardiovascular or pulmonary disease in which exercise is contraindicated
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gazi Universitylead
Study Sites (1)
Gazi University
Ankara, Turkey (Türkiye)
Related Publications (4)
Sahin F, Yilmaz F, Ozmaden A, Kotevolu N, Sahin T, Kuran B. Reliability and validity of the Turkish version of the Berg Balance Scale. J Geriatr Phys Ther. 2008;31(1):32-7. doi: 10.1519/00139143-200831010-00006.
PMID: 18489806BACKGROUNDYelnik A, Bonan I. Clinical tools for assessing balance disorders. Neurophysiol Clin. 2008 Dec;38(6):439-45. doi: 10.1016/j.neucli.2008.09.008. Epub 2008 Oct 18.
PMID: 19026963BACKGROUNDArmutlu K, Korkmaz NC, Keser I, Sumbuloglu V, Akbiyik DI, Guney Z, Karabudak R. The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients. Int J Rehabil Res. 2007 Mar;30(1):81-5. doi: 10.1097/MRR.0b013e3280146ec4.
PMID: 17293726BACKGROUNDArmutlu K, Keser I, Korkmaz N, Akbiyik DI, Sumbuloglu V, Guney Z, Karabudak R. Psychometric study of Turkish version of Fatigue Impact Scale in multiple sclerosis patients. J Neurol Sci. 2007 Apr 15;255(1-2):64-8. doi: 10.1016/j.jns.2007.01.073. Epub 2007 Mar 6.
PMID: 17337007BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cagla Ozkul
Gazi University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
April 10, 2018
First Posted
April 18, 2018
Study Start
April 9, 2018
Primary Completion
September 1, 2018
Study Completion
September 1, 2018
Last Updated
October 12, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share
There is not a plan to make IPD available.